They're paying the new CEO with a fair slice of the pie...

They're paying the new CEO with a fair slice of the pie considering current revenues or lack thereof $30k sign on as well. The options package looks extensive too!

I hope he hits whatever targets he needs for them and i think the coming quarter may see some numbers in the 4C financial statement of cash flows with the following quarter seeing some decent numbers. US is the key market and undoubtedly the new CEO will look to be establishing a name there on favourable terms.

As for a takeover by Resmed established sales channels would be needed. Synergies and scope of distribution do not currently exist between the business models until KSX build a model and name with their product that generates solid revenue.

Once channels are established it becomes an increasingly appealing play as it is likely to be EPS accretive to the acquiring company if a reasonable price/premium is paid. Still some way to go though.